Genelux Statistics

Total Valuation

Genelux has a market cap or net worth of $164.04 million. The enterprise value is $132.03 million.

Market Cap	164.04M
Enterprise Value	132.03M

Important Dates

The next estimated earnings date is Monday, March 31, 2025, before market open.

Earnings Date	Mar 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Genelux has 34.10 million shares outstanding. The number of shares has increased by 47.42% in one year.

Current Share Class	34.10M
Shares Outstanding	34.10M
Shares Change (YoY)	+47.42%
Shares Change (QoQ)	+16.31%
Owned by Insiders (%)	16.44%
Owned by Institutions (%)	14.27%
Float	26.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20,505.54
Forward PS	n/a
PB Ratio	4.96
P/TBV Ratio	4.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16,503.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.47, with a Debt / Equity ratio of 0.06.

Current Ratio	6.47
Quick Ratio	6.13
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4,824.83

Financial Efficiency

Return on equity (ROE) is -96.85% and return on invested capital (ROIC) is -59.27%.

Return on Equity (ROE)	-96.85%
Return on Assets (ROA)	-48.68%
Return on Invested Capital (ROIC)	-59.27%
Return on Capital Employed (ROCE)	-83.39%
Revenue Per Employee	$348
Profits Per Employee	-$1.20M
Employee Count	23
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.35% in the last 52 weeks. The beta is -1.51, so Genelux's price volatility has been lower than the market average.

Beta (5Y)	-1.51
52-Week Price Change	-35.35%
50-Day Moving Average	3.32
200-Day Moving Average	2.76
Relative Strength Index (RSI)	58.52
Average Volume (20 Days)	331,393

Short Selling Information

The latest short interest is 1.87 million, so 5.47% of the outstanding shares have been sold short.

Short Interest	1.87M
Short Previous Month	1.64M
Short % of Shares Out	5.47%
Short % of Float	7.18%
Short Ratio (days to cover)	7.02

Income Statement

In the last 12 months, Genelux had revenue of $8,000 and -$27.66 million in losses. Loss per share was -$0.94.

Revenue	8,000
Gross Profit	8,000
Operating Income	-28.95M
Pretax Income	-25.78M
Net Income	-27.66M
EBITDA	-28.68M
EBIT	-28.95M
Loss Per Share	-$0.94

Full Income Statement

Balance Sheet

The company has $34.06 million in cash and $2.04 million in debt, giving a net cash position of $32.02 million or $0.94 per share.

Cash & Cash Equivalents	34.06M
Total Debt	2.04M
Net Cash	32.02M
Net Cash Per Share	$0.94
Equity (Book Value)	33.09M
Book Value Per Share	0.97
Working Capital	30.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.84 million and capital expenditures -$528,000, giving a free cash flow of -$24.36 million.

Operating Cash Flow	-23.84M
Capital Expenditures	-528,000
Free Cash Flow	-24.36M
FCF Per Share	-$0.71

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-361,862.50%
Pretax Margin	-345,750.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genelux does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.42%
Shareholder Yield	-47.42%
Earnings Yield	-16.86%
FCF Yield	-14.85%

Analyst Forecast

The average price target for Genelux is $18.25, which is 279.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.25
Price Target Difference	279.42%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	230.40%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genelux has an Altman Z-Score of 7.42 and a Piotroski F-Score of 2.

Altman Z-Score	7.42
Piotroski F-Score	2